Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer

Implications for diagnosis and therapy

James C. Sisson, Robert J. Ackermann, Michael A. Meyer, Richard L. Wahl

Research output: Contribution to journalArticle

Abstract

A patient developed & pulmonary metastasis from papillary thyroid carcinoma. This tumor concentrated relatively little 131I, but sufficient 18F-fluoro-2-deoxy-D-glucose (FDG) to be quantified and imaged by positron emission tomography. The uptake of FDG was lower on positron emission tomographic images after T4 therapy and when the serum TSH concentration was reduced to the low normal range. It may be possible to use decreases in FDG uptake by thyroid cancers, which represent declines in metabolism by the tumors, to indicate the optimum doses of T4 treatment for patients with these neoplasms. In addition, the ratio of tumor to background radioactivity was higher for FDG than for the flow agent 201Tl, so that studies with FDG may be a useful scintigraphic method for locating thyroid cancers when radioiodine imaging is unsatisfactory.

Original languageEnglish (US)
Pages (from-to)1090-1094
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Volume77
Issue number4
StatePublished - Oct 1993
Externally publishedYes

Fingerprint

Deoxyglucose
Thyroid Neoplasms
Tumors
Neoplasms
Therapeutics
Positron emission tomography
Radioactivity
Positrons
Metabolism
Positron-Emission Tomography
Reference Values
Electrons
Neoplasm Metastasis
Imaging techniques
Lung
Serum

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer : Implications for diagnosis and therapy. / Sisson, James C.; Ackermann, Robert J.; Meyer, Michael A.; Wahl, Richard L.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 77, No. 4, 10.1993, p. 1090-1094.

Research output: Contribution to journalArticle

Sisson, James C. ; Ackermann, Robert J. ; Meyer, Michael A. ; Wahl, Richard L. / Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer : Implications for diagnosis and therapy. In: Journal of Clinical Endocrinology and Metabolism. 1993 ; Vol. 77, No. 4. pp. 1090-1094.
@article{57a32d1b06fb4a29983dac3b0773ee46,
title = "Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer: Implications for diagnosis and therapy",
abstract = "A patient developed & pulmonary metastasis from papillary thyroid carcinoma. This tumor concentrated relatively little 131I, but sufficient 18F-fluoro-2-deoxy-D-glucose (FDG) to be quantified and imaged by positron emission tomography. The uptake of FDG was lower on positron emission tomographic images after T4 therapy and when the serum TSH concentration was reduced to the low normal range. It may be possible to use decreases in FDG uptake by thyroid cancers, which represent declines in metabolism by the tumors, to indicate the optimum doses of T4 treatment for patients with these neoplasms. In addition, the ratio of tumor to background radioactivity was higher for FDG than for the flow agent 201Tl, so that studies with FDG may be a useful scintigraphic method for locating thyroid cancers when radioiodine imaging is unsatisfactory.",
author = "Sisson, {James C.} and Ackermann, {Robert J.} and Meyer, {Michael A.} and Wahl, {Richard L.}",
year = "1993",
month = "10",
language = "English (US)",
volume = "77",
pages = "1090--1094",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "4",

}

TY - JOUR

T1 - Uptake of 18-fluoro-2-deoxy-D-glucose by thyroid cancer

T2 - Implications for diagnosis and therapy

AU - Sisson, James C.

AU - Ackermann, Robert J.

AU - Meyer, Michael A.

AU - Wahl, Richard L.

PY - 1993/10

Y1 - 1993/10

N2 - A patient developed & pulmonary metastasis from papillary thyroid carcinoma. This tumor concentrated relatively little 131I, but sufficient 18F-fluoro-2-deoxy-D-glucose (FDG) to be quantified and imaged by positron emission tomography. The uptake of FDG was lower on positron emission tomographic images after T4 therapy and when the serum TSH concentration was reduced to the low normal range. It may be possible to use decreases in FDG uptake by thyroid cancers, which represent declines in metabolism by the tumors, to indicate the optimum doses of T4 treatment for patients with these neoplasms. In addition, the ratio of tumor to background radioactivity was higher for FDG than for the flow agent 201Tl, so that studies with FDG may be a useful scintigraphic method for locating thyroid cancers when radioiodine imaging is unsatisfactory.

AB - A patient developed & pulmonary metastasis from papillary thyroid carcinoma. This tumor concentrated relatively little 131I, but sufficient 18F-fluoro-2-deoxy-D-glucose (FDG) to be quantified and imaged by positron emission tomography. The uptake of FDG was lower on positron emission tomographic images after T4 therapy and when the serum TSH concentration was reduced to the low normal range. It may be possible to use decreases in FDG uptake by thyroid cancers, which represent declines in metabolism by the tumors, to indicate the optimum doses of T4 treatment for patients with these neoplasms. In addition, the ratio of tumor to background radioactivity was higher for FDG than for the flow agent 201Tl, so that studies with FDG may be a useful scintigraphic method for locating thyroid cancers when radioiodine imaging is unsatisfactory.

UR - http://www.scopus.com/inward/record.url?scp=0027441026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027441026&partnerID=8YFLogxK

M3 - Article

VL - 77

SP - 1090

EP - 1094

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 4

ER -